Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis

Clinical trial NCT02065154 · COMPLETED

Trial details

NCT number: NCT02065154
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Lymphoma Myelodysplastic Syndrome Myelofibrosis Severe Aplastic Anemia Allogeneic Transplant

Start date: 2013-08-27
Primary completion: 2022-04-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.